LIXTE Biotechnology Holdings joins Russell Microcap Index

1 min read     Updated on 26 Jun 2026, 06:35 PM
scanx
Reviewed by
Shraddha JScanX News Team
AI Summary

LIXTE Biotechnology Holdings, Inc. joins the Russell Microcap Index, effective June 29, 2026, boosting visibility among institutional investors. CEO Geordan Pursglove cites the move as a milestone in the company's transformation into AI energy infrastructure. The Russell Microcap Index benchmarks smaller U.S. publicly traded companies.

powered bylight_fuzz_icon
44024709

*this image is generated using AI for illustrative purposes only.

LIXTE Biotechnology Holdings, Inc. has been included in the Russell Microcap Index, effective after the close of the U.S. equity markets on June 26, 2026. The reconstituted indexes will take effect at the opening of trading on June 29, 2026, as part of the annual Russell U.S. Indexes reconstitution. This inclusion marks a significant milestone for the company, reflecting its progress over the past year and its strategic transformation.

Geordan Pursglove, Chief Executive Officer of LIXTE, stated that the company has successfully transformed under new leadership and strategic direction. He emphasized that membership in the Russell Microcap Index will increase visibility among institutional investors and broaden awareness of its growth strategy. The company is currently pivoting to focus on AI energy infrastructure equipment and services, aiming to support the power and infrastructure needs of AI and hyperscale data centers.

The Russell Microcap Index measures the performance of smaller publicly traded U.S. companies and serves as a benchmark for active and passive microcap investment strategies. Russell indexes are reconstituted annually to reflect changes in the U.S. equity market and ensure growing companies are appropriately represented. Membership provides exposure to investment products and funds that benchmark their performance against Russell indexes.

LIXTE Biotechnology Holdings, Inc. is a holding company historically focused on developing cancer therapies and medical technologies. It is now executing a strategic transformation into an AI energy infrastructure equipment and services platform. The company aims to capitalize on the accelerating demand for reliable, scalable, and efficient energy infrastructure solutions driven by the global expansion of AI.

Key Details Information
Company LIXTE Biotechnology Holdings, Inc.
Index Russell Microcap Index
Effective Date June 29, 2026
CEO Geordan Pursglove
Strategic Focus AI energy infrastructure equipment and services

What specific capital requirements does LIXTE anticipate needing to fund its pivot into AI energy infrastructure?

How will the company's historical focus on biotechnology impact investor confidence as it transitions to the energy sector?

What partnerships or acquisitions is LIXTE pursuing to rapidly establish credibility in the hyperscale data center market?

like17
dislike

LIXTE loans $6.5M to NOMAD ahead of July 1 closing

2 min read     Updated on 18 Jun 2026, 09:22 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

LIXTE Biotechnology Holdings, Inc. agreed to loan $6.5 million to NOMAD Transportable Power Systems, Inc. to fund working capital and component procurement before their acquisition closes on July 1, 2026. The combined entity will be renamed NOMAD Power Solutions, Inc., focusing on deployable utility-grade battery energy storage systems to address power constraints from AI and grid modernization. NOMAD reported approximately 175% revenue growth in 2025 and projects 135% growth in 2026.

powered bylight_fuzz_icon
42814390

*this image is generated using AI for illustrative purposes only.

LIXTE Biotechnology Holdings, Inc. will loan $6.5 million to NOMAD Transportable Power Systems, Inc. prior to the anticipated closing of their acquisition to fund order backlog and working capital needs. The transaction is expected to close on or about July 1, 2026, subject to customary closing conditions and required approvals. Upon closing, the combined entity will be renamed NOMAD Power Solutions, Inc. and will trade on the Nasdaq Stock Market under a new ticker symbol, positioning the firm to address power availability constraints driven by artificial intelligence, electrification, and grid modernization.

The loan proceeds are intended to fund the procurement of long-lead components against NOMAD's active order pipeline and to support working capital as NOMAD scales manufacturing to meet accelerating customer demand. Deploying capital ahead of closing is designed to ensure NOMAD can convert its growing backlog into delivered systems without interruption to its production cadence. "Putting capital to work now, ahead of closing, reflects our conviction in NOMAD's platform and attempting to fulfill the demand we are seeing," said Geordan Pursglove, chief executive of LIXTE Biotechnology Holdings, Inc.

NOMAD pioneered the deployable utility-grade battery energy storage systems (BESS) category and is the first company to bring a mobile, utility-grade 1 MW BESS to market. The platform meets performance, safety, and interconnection standards required by investor-owned utilities, electric cooperatives, municipal utilities, and large industrial energy users. The system features UL 9540 full-system validation and a multi-year track record of utility-scale deployment. The structural permitting advantage of NOMAD's mobile, transportable BESS architecture allows it to be deployed as equipment rather than permanent infrastructure, generally bypassing land use entitlements, environmental reviews, and interconnection queues.

NOMAD has delivered exceptional revenue growth driven by structural demand for deployable, utility-grade power infrastructure. Revenue grew approximately 175% year-over-year in 2025, with management projecting further growth of approximately 135% year-over-year in 2026. Approximately 75% of sales activity is inbound, and the company is engaged on more than 30 active utility, infrastructure, and strategic customer opportunities across North America. "The acceleration in demand from AI infrastructure and data center customers confirms that deployable, utility-grade storage is becoming an essential layer of the modern grid," said John Travaglini, chief executive of NOMAD.

Key Financial and Operational Metrics

Metric Value
Revenue Growth (2025) ~175% YoY
Projected Revenue Growth (2026) ~135% YoY
Inbound Sales Activity ~75%
Active Customer Opportunities >30

How will the combined entity manage the integration risks between a biotechnology firm and a power systems manufacturer?

What specific strategies will NOMAD employ to scale manufacturing capacity to sustain the projected 135% revenue growth in 2026?

To what extent will the surge in AI infrastructure demand continue to drive inbound sales volume beyond the current fiscal year?

like16
dislike